FDA gives priority review to brain-controlled prosthetics

The FDA is evaluating brain-powered prosthetic limbs developed by the Defense Advanced Research Project Agency. It's a move "to restore near-natural arm, hand and finger function to patients suffering from spinal cord injury, stroke or amputation," according to an FDA release.

The prosthetic limbs are controlled by a microchip implanted in the patient's brain. The chip will record neuron signals from the brain to control muscles connected to the prosthesis. The devices will be the first tested in the FDA's new Innovation Pathway, which stimulates priority review for breakthrough devices.

- read the LA Times story

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.